In this article
- What opioid dependency does to the brain
- Why stopping is not a matter of willpower
- The overdose risk - what families need to know
- What withdrawal looks like and why it drives relapse
- Methadone and buprenorphine - harm reduction explained
- How to talk to someone in opioid addiction
- What families should not do
- The treatment pathway
- Taking care of yourself as a family member
What opioid dependency does to the brain
Opioids - whether heroin, fentanyl, oxycodone, morphine, or codeine - work by binding to opioid receptors in the brain. These receptors are part of the body's natural pain and reward system. When opioids bind to them, they trigger a cascade of dopamine release that produces intense euphoria, pain relief, and a sense of calm that is physiologically unlike anything the brain produces naturally.
With repeated use, the brain adapts. It downregulates its own opioid receptor sensitivity and reduces natural endorphin production. The person is no longer using opioids to get high - they are using them to feel approximately normal. Without the drug, the brain's reward and regulatory systems do not function adequately. This is physiological dependency, and it is not a matter of character or willpower. The brain has been altered at a neurochemical level in ways that take months to years to fully resolve.
Understanding this is the most important thing a family member can do. The behaviour they are witnessing - the lies, the prioritisation of the drug over everything else, the apparent indifference to consequences - is not a choice in the ordinary sense. It is a brain operating under conditions of dependency that change the relative weight of everything.
Why stopping is not a matter of willpower
The framing of addiction as a failure of willpower is not only clinically wrong - it is actively harmful, because it puts the family in an impossible relationship with the person they are trying to help. If it is about willpower, then love and enough pressure should be sufficient. When they are not, the family concludes that the love is not strong enough or that the person does not care. Neither is true.
Is this something you're dealing with?
Free confidential advice - no pressure, no obligation.
Opioid dependency is characterised by a loss of control over use that is neurological, not volitional. The prefrontal cortex - the part of the brain involved in judgement, future planning, and impulse control - is functionally compromised in people with opioid use disorder. The decision-making that seems straightforward from the outside is happening in a brain that is not operating normally. Treatment addresses this at both the neurological and psychological levels in ways that willpower cannot.
The overdose risk - what families need to know
Opioid overdose is now the leading cause of accidental death in many Western countries, and the risk has increased dramatically with the widespread contamination of illicit drug supplies with fentanyl and its analogues. Fentanyl is fifty to one hundred times more potent than morphine. A quantity invisible to the naked eye can be fatal. Someone who believes they are using heroin may in fact be using a product that is primarily fentanyl - and a dose calibrated to their heroin tolerance can be many times a lethal dose of fentanyl.
Families should know the signs of opioid overdose: pinpoint pupils, unconsciousness or unresponsiveness, slow or stopped breathing, blue or grey lips. Naloxone (sold as Narcan in many countries) is an opioid antagonist that can reverse an overdose in minutes. It is available without prescription in many jurisdictions, and families of people using opioids should have it and know how to use it. Administering naloxone is not enabling - it is keeping someone alive long enough to receive treatment.
What withdrawal looks like and why it drives relapse
Opioid withdrawal is not life-threatening in the way that alcohol or benzodiazepine withdrawal can be - but it is profoundly physically and psychologically distressing. The experience has been compared to a severe flu combined with extreme anxiety, bone pain, gastrointestinal distress, insomnia, and a psychological state of desperate craving. It typically peaks at 24 to 72 hours after the last use and can persist in attenuated form for weeks.
This is the central mechanism driving relapse in the early stages. The discomfort of withdrawal is so acute that using again provides immediate relief. The brain learns this relief rapidly and powerfully - which is why the cycle is so hard to break without medical support. Families watching someone repeatedly stop and restart are not watching a failure of commitment. They are watching the neurological trap that opioid dependency creates.
Medically supervised detox manages withdrawal with medications that significantly reduce its severity - making the process bearable and dramatically reducing the likelihood of early relapse.
Methadone and buprenorphine - harm reduction explained
Medication-assisted treatment (MAT) with methadone or buprenorphine (often branded as Suboxone or Subutex) is among the most evidence-supported interventions in all of addiction medicine. Both are opioid agonists - they bind to opioid receptors and prevent withdrawal - but are taken in controlled doses under medical supervision, without producing the intense euphoria of heroin or fentanyl.
For some people, MAT is a bridge - stabilising them and enabling engagement with therapy while the longer process of full abstinence is worked towards. For others, long-term maintenance is the appropriate treatment. The evidence is clear that people maintained on methadone or buprenorphine have dramatically lower rates of overdose, criminal behaviour, and mortality than those attempting abstinence without medication support.
Families sometimes resist MAT because it feels like "still using drugs." The clinical evidence does not support this resistance. MAT saves lives and enables functioning. Whether it is a long-term solution or a step towards full abstinence is a clinical decision made with the individual - not a moral position to be taken from outside.
How to talk to someone in opioid addiction
The conversations families have with someone in active opioid addiction are among the most difficult they will ever have. A few principles help:
- Separate the person from the addiction. The behaviour being described is the addiction's behaviour - it is not who the person is.
- Express concern about safety rather than moral judgement. "I'm scared I'm going to lose you" is more likely to reach someone than "what you're doing is destroying our family."
- Communicate that help is available and that the path to it is open. Giving up the pretence that things are manageable is much easier when the alternative is concrete rather than abstract.
- Do not try to have significant conversations when the person is using or in withdrawal. The neurological state is not one in which meaningful engagement with the future is possible.
What families should not do
The instinct to protect someone you love from consequences is understandable. In opioid addiction, it is usually harmful. Providing money that is likely to be used to purchase drugs, covering debts, making excuses to employers or other family members, and shielding the person from the natural consequences of their use all reduce the pressure that might otherwise motivate change. This is not a moral judgement - it is a clinical one.
Equally harmful is the ultimatum delivered without genuine follow-through. Consequences that are threatened and not applied teach the person that the threats are not real. If a boundary is set, it must be maintained - which means only setting boundaries one is actually prepared to hold.
The treatment pathway
For opioid dependency, effective treatment typically involves several stages: medically supervised detoxification; residential rehabilitation with intensive individual and group therapy; medication-assisted treatment where clinically indicated; and a structured aftercare plan including ongoing therapy, peer support, and relapse prevention work. These stages are not always linear, and relapse during the process does not mean treatment has failed - it means the treatment plan needs adjustment.
Residential treatment provides the immersive, supported environment in which the psychological work of recovery can happen. The physical distance from the drug supply and the social environment associated with using is itself clinically significant, particularly in early recovery when the neural pathways associated with craving are most easily triggered by environmental cues.
Taking care of yourself as a family member
Families of people with opioid addiction experience a specific and well-documented form of trauma. The hypervigilance, the anticipatory grief, the exhaustion of sustained crisis management, the effect on other family members - these are real and they require attention. Support for families is not a luxury - it is part of the treatment system for the person with addiction, because families are the primary social environment that either supports or undermines recovery.
Al-Anon, SMART Recovery Family and Friends, and individual therapy for family members are all evidence-supported approaches to supporting family wellbeing. A family that is better supported is better placed to play the role that recovery requires of them.
Opioid dependency is a medical condition with effective treatments. The question is not whether recovery is possible - it is how to access the right support at the right time.
Worried about someone you love?
Free confidential advice for families. We can help you understand the options and the next steps.
